Urea, N-[3,5-dichloro-4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]-N'-[3-(trifluoromethyl)phenyl]-

Urea, N-[3,5-dichloro-4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]-N'-[3-(trifluoromethyl)phenyl]- Struktur
1268490-12-5
CAS-Nr.
1268490-12-5
Englisch Name:
Urea, N-[3,5-dichloro-4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]-N'-[3-(trifluoromethyl)phenyl]-
Synonyma:
GSK329;T24109;GSK-329;GSK 329;GSK329, 10 mM in DMSO;3-(3,5-dichloro-4-{[6-(methylamino)pyrimidin-4-yl]oxy}phenyl)-1-[3-(trifluoromethyl)phenyl]urea;N-[3,5-Dichloro-4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]-N-[3-(trifluoromethyl)phenyl]-urea;Urea, N-[3,5-dichloro-4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]-N'-[3-(trifluoromethyl)phenyl]-;diarylurea,cardiac-specific kinase,cardioprotective outcomes,inhibit,Inhibitor,GSK329,ischemia/reperfusion,TNNI3K
CBNumber:
CB19816180
Summenformel:
C19H14Cl2F3N5O2
Molgewicht:
472.25
MOL-Datei:
1268490-12-5.mol

Urea, N-[3,5-dichloro-4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]-N'-[3-(trifluoromethyl)phenyl]- Eigenschaften

Siedepunkt:
471.0±45.0 °C(Predicted)
Dichte
1.554±0.06 g/cm3(Predicted)
storage temp. 
4°C, protect from light
Löslichkeit
DMSO : 250 mg/mL (529.38 mM; Need ultrasonic)
pka
12.00±0.70(Predicted)
Aggregatzustand
Solid
Farbe
White to off-white

Sicherheit

Urea, N-[3,5-dichloro-4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]-N'-[3-(trifluoromethyl)phenyl]- Chemische Eigenschaften,Einsatz,Produktion Methoden

Urea, N-[3,5-dichloro-4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]-N'-[3-(trifluoromethyl)phenyl]- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Urea, N-[3,5-dichloro-4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]-N'-[3-(trifluoromethyl)phenyl]- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 31)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 33024 60
TargetMol Chemicals Inc.
+1-781-999-5354; +17819995354
marketing@targetmol.com United States 32435 58
Wuhan Jingkang en Biomedical Technology Co., Ltd
+8613720134139
orders@jknbiochem.com China 5221 58
Nanjing Chemlin Chemical Co., Ltd 025-83697070
info@chemlin.com.cn China 16077 64
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266
China 4768 55
Shanghai Beckham Medical Technology Co., Ltd 13816613772
huahero21@sina.com China 2391 55
Shanghai YuanYe Biotechnology Co., Ltd. 021-61312847; 18021002903
3008007409@qq.com China 71826 60
Shanghai Chaolan Chemical Technology Center 021-QQ:65489617 15618227136
Sales@ATKchemical.com China 9125 58
Shanghai Yu Ben Biotechnology Co., Ltd. 021-61350663 15502154572
1639466865@qq.com China 498 58
Shanghai Dongyang Biotechnology Co., Ltd. 0512-0512-13601744364 13601744364
chemsharker@126.com China 1010 58

  • Urea, N-[3,5-dichloro-4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]-N'-[3-(trifluoromethyl)phenyl]-
  • GSK 329
  • GSK329
  • GSK-329
  • T24109
  • diarylurea,cardiac-specific kinase,cardioprotective outcomes,inhibit,Inhibitor,GSK329,ischemia/reperfusion,TNNI3K
  • 3-(3,5-dichloro-4-{[6-(methylamino)pyrimidin-4-yl]oxy}phenyl)-1-[3-(trifluoromethyl)phenyl]urea
  • GSK329, 10 mM in DMSO
  • N-[3,5-Dichloro-4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]-N-[3-(trifluoromethyl)phenyl]-urea
  • 1268490-12-5
Copyright 2019 © ChemicalBook. All rights reserved